The RestoreX® Penile Traction Therapy Device was developed in cooperation with Mayo Clinic. The system is for treatment of Peyronie’s disease and to correct lost penile length resulting from urological surgeries and treatments or chronic disease. Invented by a Urologist specialising in Men’s Sexual Health, the RestoreX® system is about optimising user and patient outcomes.
- Easy to use
- No surgery
- No needles
The RestoreX® Penile Traction Therapy Device is designed for the treatment of:
An easy and effective solution for treating curvature and lost length resulting from Peyronie’s disease.
An easy-to-use solution to maintain penile length after prostatectomy.
The RestoreX® device is to be used for a total of 60-minutes per day, spread over 2, 30-minute treatments. The design of the system and instructions for use make the device simple and easy to use.
Results for the treatment of curvature and lost length resulting from Peyronie’s disease¹
- Results for 2, 30-minute treatments per day for 12 weeks
- 94% of men gained length; average of 1.6cm or 11%
- 77% of men reduced curvature; average of 17° or 28%
- 73% reported improved ability for sexual activity
- 100% preferred RestoreX over other traction devices
Results for maintaining penile length after prostatectomy²
- Results in just 2, 30-minute treatments per day for 5 months
- Start treatment sessions 1 month after surgery
- On average, men using RestoreX gained 2cm in length
- Erectile function only declined 4 points while men that did not use RestoreX (control group) lost 8 points, on average, due to their surgery
- 83% of men indicated the treatment was meaningful and worthwhile
- No long-term complications were associated with RestoreX treatment
ALWAYS READ THE INSTRUCTIONS FOR USE.
- Outcomes of a Novel Penile Traction Device in Men with Peyronie’s Disease: A Randomized, Single-Blind, Controlled Trial, Journal of Urology, Sept. 2019, Vol. 202, 599-610. Trost, L., et al.
- Efficacy of RestoreX penile traction therapy in improving length and erectile function post-prostatectomy. Presentation at the Western Section of the AUA, November 2019, Trost, L., et al.